Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Related Posts
European markets open lower as positive sentiment vanishes
European markets opened in negative territory Tuesday as investors geared up for the latest U.S. inflation report this week.
Leon Cooperman says he’s selling into market strength and holding lots of cash
The chairman of Omega Family Office expressed hesitation about the market outlook in a CNBC interview, saying “I don’t like what I see.”
China’s bond yields are rising — but economists say deflation worries could soon pull them lower
Chinese commercial banks across the country have rushed to dole out cheaper consumption loans, heeding Beijing’s call to bolster spending.